Fingolimod 0.50mg Capsule

Fingolimod 0.50mg Capsule
Product Description

Description: Oral immunomodulatory medication used primarily in the treatment of relapsing forms of multiple sclerosis. It helps reduce disease activity and progression.

Therapeutic Category: Immunomodulator / Neurology

Mechanism of Action (MOA):
Fingolimod modulates sphingosine-1-phosphate (S1P) receptors, preventing lymphocytes from exiting lymph nodes and reducing their migration into the central nervous system.

This helps:
• Reduce frequency of multiple sclerosis relapses
• Slow progression of disability
• Decrease inflammation and nerve damage in the brain and spinal cord
• Improve overall disease control

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swasthya Healthcare Private Limited (31)

  • Dolutegravir, Tenofovir Disoproxil Fumarate & Lamivudine Tablets

    Product Dolutegravir, Tenofovir Disoproxil Fumarate & Lamivudine Tablets

    Description: Fixed-dose combination oral formulation containing dolutegravir, tenofovir, and lamivudine. This antiretroviral regimen is designed for once-daily use and is widely used in the treatment of HIV-1 infection, offering a potent and well-tolerated therapy.

    Therapeutic Category: Antire...
  • Abiraterone Acetate Tablets USP 250 mg

    Product Abiraterone Acetate Tablets USP 250 mg

    Description: Oral anticancer medication containing abiraterone acetate, used in the treatment of metastatic prostate cancer. It is typically administered along with corticosteroids to enhance therapeutic effect.

    Therapeutic Category: Antineoplastic / Hormonal Therapy
    ...
  • Sorafenib Tablet 200mg

    Product Sorafenib Tablet 200mg

    Description: Oral anticancer medication containing sorafenib, a multikinase inhibitor used in the treatment of certain advanced cancers. It is commonly prescribed for liver, kidney, and thyroid cancers.

    Therapeutic Category: Antineoplastic / Targeted Therapy...
  • Ibrutinib Capsules 140 mg

    Product Ibrutinib Capsules 140 mg

    Description: Oral targeted anticancer medication containing ibrutinib, used in the treatment of various B-cell malignancies such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma.

    Therapeutic Category: Antineoplastic / Targeted Therapy

    ...
  • Bortezomib Injection 3.5 mg

    Product Bortezomib Injection 3.5 mg

    Description: Sterile injectable formulation containing bortezomib, a proteasome inhibitor used in the treatment of certain hematological cancers. Administered intravenously or subcutaneously under medical supervision.

    Therapeutic Category: Antineoplastic / Targeted Therapy ...
  • Deferasirox 250mg

    Product Deferasirox 250mg

    Description: Oral iron chelating agent used for the treatment of chronic iron overload caused by repeated blood transfusions. Available as film-coated or dispersible tablets.

    Therapeutic Category: Iron Chelator / Hematology

    Mechanism of Action (MOA): Deferasirox b...
  • Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Product Enoxaparin Sodium Injection USP 40 mg/0.4 ml

    Description: Sterile injectable solution containing enoxaparin sodium, a low molecular weight heparin (LMWH) used for prevention and treatment of blood clots. Administered subcutaneously or intravenously under medical supervision.

    Therapeutic Category: Antic...
  • Venetoclax Tablets 100 mg

    Product Venetoclax Tablets 100 mg

    Description: Oral targeted anticancer medication containing venetoclax, primarily used in the treatment of certain hematological malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

    Therapeutic Category: Antineoplastic / Targeted Therapy...
  • Apalutamide Tablets

    Product Apalutamide Tablets

    Description: Oral anticancer medication containing apalutamide, used in the treatment of prostate cancer. It is designed to inhibit androgen receptor signaling involved in tumor growth.

    Therapeutic Category: Antineoplastic / Hormonal Therapy / Targeted Therapy

    ...
  • Eltrombopag 25mg

    Product Eltrombopag 25mg

    Description: Oral medication containing eltrombopag, a thrombopoietin receptor agonist used to increase platelet production in patients with certain hematological conditions.

    Therapeutic Category: Thrombopoietin Receptor Agonist / Hematologic Agent
    ...
  • Mirogabalin Besylate

    Product Mirogabalin Besylate

    Description: Oral neuropathic pain management therapy containing mirogabalin besylate, developed to provide targeted relief in peripheral neuropathic pain conditions. Designed for effective symptom control with improved patient tolerability.

    Therapeutic Category: Neurology ...
  • Acalabrutinib Capsule 100 mg

    Product Acalabrutinib Capsule 100 mg

    Description: Oral capsule formulation of acalabrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor. It is designed to interfere with B-cell receptor signaling, thereby reducing the growth and survival of malignant B-cells. Commonly used in the treatment of certain hematological malignancies.
    ...

Swasthya Healthcare Private Limited resources (5)

  • Brochure USA REGISTERED PRODUCTS

    Carfilzomib Powder for Infusion 60 mg       Introduction: Anticancer medicine used to treat multiple myeloma. 
    Use: For relapsed or refractory multiple myeloma, alone or in combination with other therapies. 
    MOA: Irreversibly inhibits the 20S proteasome, causing accumulation of proteins in cancer cells and inducing apoptosis. 
    Amphotericin B Liposomal Injection 50 mg 
    Introduction: Liposomal antifungal medicine for treating severe systemic fungal infections. 
    Use: Treats invasive fungal infections, visceral leishmaniasis, and is used as empirical therapy in febrile neutropenic patients. 
    MOA: Binds to ergosterol in fungal cell membranes, forms pores, and causes fungal cell death. The liposomal formulation reduces kidney toxicity while improving targeted drug delivery.
  • Brochure Swasthya Healthcare Product List Brochure

    Swasthya Healthcare Product List Brochure
  • Brochure SWASTHYA HEALTHCARE PRESENTATION

    Swasthya Healthcare is an integrated pharmaceutical company from India & has offices in UAE, Singapore, and Guatemala with a strong presence across Latin America, including El Salvador, Guatemala, Bolivia, and Nicaragua. We specialize in a wide range of product categories including Oncology, Antiretrovirals (ARVs), Contrast Media, and Critical Care products.

  • Brochure CONTRAST MEDIA PRESENTATION

    Swasthya Healthcare--CONTRAST MEDIA PRODUCT RANGE